- Home
- CFB vs CSTL Comparison
CFB vs CSTL Comparison
Compare CFB & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFB
- CSTL
- Stock Information
- Founded
- CFB 2007
- CSTL 2007
- Country
- CFB United States
- CSTL United States
- Employees
- CFB N/A
- CSTL N/A
- Industry
- CFB Major Banks
- CSTL Medical Specialities
- Sector
- CFB Finance
- CSTL Health Care
- Exchange
- CFB Nasdaq
- CSTL Nasdaq
- Market Cap
- CFB 751.6M
- CSTL 848.1M
- IPO Year
- CFB 2019
- CSTL 2019
- Fundamental
- Price
- CFB $15.24
- CSTL $24.94
- Analyst Decision
- CFB Strong Buy
- CSTL Strong Buy
- Analyst Count
- CFB 4
- CSTL 6
- Target Price
- CFB $19.50
- CSTL $40.33
- AVG Volume (30 Days)
- CFB 178.1K
- CSTL 434.0K
- Earning Date
- CFB 01-28-2025
- CSTL 02-26-2025
- Dividend Yield
- CFB N/A
- CSTL N/A
- EPS Growth
- CFB 19.65
- CSTL N/A
- EPS
- CFB 1.47
- CSTL 0.21
- Revenue
- CFB $242,671,000.00
- CSTL $311,878,000.00
- Revenue This Year
- CFB N/A
- CSTL $51.29
- Revenue Next Year
- CFB $9.11
- CSTL N/A
- P/E Ratio
- CFB $10.37
- CSTL $118.55
- Revenue Growth
- CFB 7.66
- CSTL 62.43
- 52 Week Low
- CFB $10.64
- CSTL $16.97
- 52 Week High
- CFB $19.22
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- CFB 46.84
- CSTL 36.58
- Support Level
- CFB $14.60
- CSTL $23.95
- Resistance Level
- CFB $15.19
- CSTL $26.52
- Average True Range (ATR)
- CFB 0.41
- CSTL 2.08
- MACD
- CFB 0.07
- CSTL -0.36
- Stochastic Oscillator
- CFB 71.27
- CSTL 11.26
About CFB CrossFirst Bankshares Inc.
CrossFirst Bankshares Inc is engaged in providing banking and financial services to businesses, business owners, professionals, and professional networks. The services offered by the company includes Checking accounts, Savings accounts, Personal Loans, International Banking, Business Loans, and Treasury services. The company generates revenue from interest income and fees on loans and interest earned from its marketable securities portfolio.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.